Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.58 |
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.44 |
| ▸ | CCKAR | P32238 | 5/20 | 0.39 |
| ▸ | CCKBR | P32239 | 5/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12518541 | 0.90 | GLP1R (0.62) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL12424093 | 0.90 | GLP1R (0.62) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL21127452 | 0.88 | GLP1R (0.55) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL21172234 | 0.88 | GLP1R (0.54) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL2373340 | 0.86 | GLP1R (0.69) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL22627089 | 0.85 | GLP1R (0.56) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL15871469 | 0.84 | GLP1R (0.62) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL16093455 | 0.84 | GLP1R (0.62) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL16093448 | 0.84 | GLP1R (0.54) | GLP1RNOD1CCKARCCKBR | |
| SCHEMBL21126547 | 0.84 | GLP1R (0.54) | GLP1RNOD1CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |